Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor, Paraganglioma and Epithelioid Hemangioendothelioma: Three Case Reports

Sunitinib malate (Sutent(TM); Pfizer Inc., New York, N.Y., USA) is a small molecule kinase inhibitor with activity against a number of tyrosine kinase receptors, including vascular endothelial growth factor receptors, stem-cell factor receptor, and platelet-derived growth factor receptors alpha and...

Descripción completa

Detalles Bibliográficos
Autores principales: Prochilo, Tiziana, Savelli, Giordano, Bertocchi, Paola, Abeni, Chiara, Rota, Luigina, Rizzi, Anna, Zaniboni, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: February, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617978/
https://www.ncbi.nlm.nih.gov/pubmed/23626551
http://dx.doi.org/10.1159/000348429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617978/
https://www.ncbi.nlm.nih.gov/pubmed/23626551
http://dx.doi.org/10.1159/000348429

Ejemplares similares